Genetic polymorphisms of the E-Cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 9, 2008, Pages 2402-2408

  Zhang, Baozhen ^a   Pan, Kaifeng ^a   Liu, Zhaojun ^a   Zhou, Jing ^a   Gu, Liankun ^a   Ji, Jiafu ^a   Ma, Junling ^a   You, Wei Cheng ^a   Deng, Dajun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ADULT; ALLELE; ARTICLE; BACTERIAL INFECTION; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SPORADIC GASTRIC CARCINOMA; STOMACH CARCINOMA; STOMACH LESION; TRANSCRIPTION INITIATION SITE;

ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENOTYPE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RISK; STOMACH NEOPLASMS;

EID: 53349176767     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0315     Document Type: Article

References (41)

1. He J, Gu DF, Wu XG, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-34.
2. International Agency for Research on Cancer. Schistosomes, liver flukes, and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. IARC 1994;61:177-241.
3. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, other risk factors. J Natl Cancer Inst 2000;92:1607-12.
4. Deng DJ. Progress of gastric cancer etiology: N-nitrosamides in the 1990s. World J Gastroenterol 2000;6:613-8.
5. Buiatti E, Munoz N. Chemoprevention of stomach cancer. IARC Sci Publ 1996;136:35-9.
6. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
7. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.
8. Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007;297:2360-72.
9. Becker KF, Atkinson MJ, Reich U, et al. E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-52.
10. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-15.
11. Berx G, Becker KF, Hofler H,van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998;12:226-37.
12. Ilyas M, Tomlinson IP, Hanby A, Talbot IC, Bodmer WF. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 1997;40:654-9.
13. Wheeler JM, Warren BF, Mortensen NJ, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002;50:218-23.
14. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53:1690-5.
15. Kinsella A, Lepts GC, Hill CL, Jones M. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 1994;12:335-42.
16. Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994;174:243-8.
17. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142:987-93.
18. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;52:5104-9.
19. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A 1995;92:7416-9.
20. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001;20:1525-8.
21. Batlle E, Sancho E, Franci C, et al. The transition factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biol 2000;2:84-9.
22. Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000;60:873-6.
23. Shin Y, Kim IJ, Kang HC, et al. The E-cadherin -347G→GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 2004;25:895-9.
24. Kuraoka K, Oue N, Yokozaki H, et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumourigenesis and progression of gastric carcinoma in Japan. Int J Oncol 2003;23:421-7.
25. Wu MS, Huang SP, Chang YT, et al. Association of the -160C→A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002;94:1443-8.
26. Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002;21:8192-5.
27. Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003;18:501-4.
28. Lu Y, Xu YC, Shen J, et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005;11:56-60.
29. Pharoah PD, Oliveira C, Machado JC, et al. CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer 2002;101:196-7.
30. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1371-21.
31. Zhang L, Blot WJ, You WC, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarker Prev 1996;5:627-30.
32. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-8.
33. Lindstrom S, Wiklund F, Jonsson BA, et al. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. Hum Genet 2005;118:339-47.
34. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615-9.
35. You WC, Blot WJ, Chang YS, et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res 1988;48:3518-23.
36. You W, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-83.
37. Song CG, Huang CM, Liu X, et al. Association of -160C>A polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005;22:557-9.
38. Zhang XF, Wang YM, Wang R, et al. Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardia adenocarcinoma. Ai Zheng 2005;24:513-9.
39. Hajra KM, Ji X, Fearon ER. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 1999;18:7274-9.
40. Hajra KM, Chen DY-S, Fearon ER. The Slug zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62:1613-8.
41. Nakamura A, Shimazaki T, Kaneko K, et al. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 2002;502:19-24.